Drugs Made In America Acquisition (DMII) Equity Ratio (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Equity Ratio of 0.04 for Q4 2025, up 95.84% year-over-year from 0.02 in Q4 2024, and down 2.05% quarter-over-quarter from 0.03 in Q3 2025.
Drugs Made In America Acquisition (DMII) Equity Ratio (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Equity Ratio data on file, last reported at 0.04 in Q4 2025.
- Equity Ratio for Q4 2025 came in at 0.04, up 95.84% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.04 (up 95.84% YoY), and the FY2025 annual result was 0.04, up 95.84% from the prior year.
- Equity Ratio declined to 0.04 in Q4 2025 per DMII's latest filing, from 0.03 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.03 in Q3 2025 and troughed at 0.85 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -0.03 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -0.05 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -0.04 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -0.04 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -0.04 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -0.04 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -0.08 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -0.03 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -0.13 |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.03 |
| Dec 31, 2024 | -0.85 |